deltatrials
Completed PHASE2 NCT00002461

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Phase II Study of Intensive Carmustine and Etoposide With Cisplatin or Cyclophosphamide, Followed By Rescue With Autologous Bone Marrow Treated In Vitro With Etoposide and/or Peripheral Blood Stem Cells Mobilized With Filgrastim (G-CSF) or Sargramostim (GM-CSF) With or Without Radiotherapy in Patients With Resistant Hodgkin's Disease or Non-Hodgkin's Lymphoma

Sponsor: Montefiore Medical Center

Conditions Lymphoma
Interventions autologous bone marrow transplantation carmustine cisplatin cyclophosphamide etoposide filgrastim in vitro-treated bone marrow transplantation peripheral blood stem cell transplantation radiation therapy sargramostim
Updated 8 times since 2017 Last updated: Aug 15, 2018 Started: Apr 30, 1988 Primary completion: Jul 31, 1991 Completion: Jul 31, 1991

A PHASE2 clinical study on Lymphoma, this trial is completed. The trial is conducted by Montefiore Medical Center and has accumulated 8 data snapshots since 1988. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Sep 2018 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Unknown Status → Completed

▶ Show 3 earlier versions

  1. Jun 2018 — Sep 2018 [monthly]

    Unknown Status PHASE2

  2. Feb 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2

  3. Jan 2017 — Feb 2017 [monthly]

    Unknown Status PHASE2

    First recorded

Apr 1988

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Montefiore Medical Center
  • National Cancer Institute (NCI)
Data source: Montefiore Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • The Bronx, United States